腹腔内布比卡因不会衰减疼痛腹腔镜胆囊切除术

作者： Zmora，28:9 等Stolik-Dollberg，ORIT 2 ;酒吧Zakai，巴拉克1，松香，丹尼1 ; Kuriansky，约瑟夫1参看Shabtai，卡察夫1 ; Perel，阿兹列尔2 ;阿亚隆，阿姆拉姆1
来源： JSLS，Laparoendoscopic外科医生，第4卷，第4号，十月学会杂志“ - 2000年12月，第301-304页（4）
发布者：Laparoendoscopic外科医生协会

腹腔内布比卡因不会衰减疼痛腹腔镜胆囊切除术.pdf (400.84 KB, 下载次数: 0)

2013-3-2 20:35 上传

点击文件名下载附件

摘要：
背景：腹腔镜胆囊切除术的住院时间短的特点。因此，在手术当天疼痛控制变得越来越重要。本研究的目的是评估腹腔镜胆囊切除术腹腔内布比卡因缓解疼痛的效果。
方法：择期腹腔镜胆囊切除术的患者60例，随机分为2组。切除胆囊后，A组，100毫克的布比卡因在50毫升的生理盐水，胆 ​​囊床和右膈下空间的安装。B组给予生理盐水没有布比卡因。疼痛评估使用的视觉/模拟规模在固定的时间间隔。
结果：无显着性差异发生在组与组之间的平均疼痛程度在1，2，4，和术后14小时。布比卡因组平均镇痛的要求是较低的，但是这并没有达到统计学意义。
结论：腹腔内布比卡因的应用并没有减弱疼痛，腹腔镜胆囊切除术，并没有任何作用存在常规使用。

Intraperitoneal Bupivacaine Does Not Attenuate Pain Following Laparoscopic Cholecystectomy
Authors: Zmora, Oded1; Stolik-Dollberg, Orit2; Bar-Zakai, Barak1; Rosin, Danny1; Kuriansky, Joseph1; Shabtai, Moshe1; Perel, Azriel2; Ayalon, Amram1
Source: JSLS, Journal of the Society of Laparoendoscopic Surgeons, Volume 4, Number 4, October - December 2000 , pp. 301-304(4)
Publisher: Society of Laparoendoscopic Surgeons

Abstract:
Background: Laparoscopic cholecystectomy is characterized by a short hospital stay. Hence, pain control on the day of surgery is increasingly important. The aim of this study was to evaluate the effect of intraperitoneal bupivacaine on pain relief following laparoscopic cholecystectomy.
Methods: Sixty patients undergoing elective laparoscopic cholecystectomy were prospectively randomized into 2 groups. Following removal of the gallbladder, group A received 100 mg of bupivacaine in 50 cc of saline, installed into the gallbladder bed and right subphrenic space. Group B received saline without bupivacaine. Pain was assessed using a visual/analog scale at fixed-time intervals.
Results: No significant difference occurred in the average pain levels between the groups at 1, 2, 4, and 14 hours postsurgery. The average analgesic requirement was lower in the bupivacaine group, but this did not reach statistical significance.
Conclusion: Application of intraperitoneal bupivacaine did not attenuate pain following laparoscopic cholecystectomy, and no role exists for its routine use.